ASML Raises 2026 Outlook as AI Chip Demand Lifts Q2 Earnings 
FDA Pilot Program Eases Rules for Nicotine Pouch Makers 
Trump Says Qatari-Donated Air Force One Jet to Undergo Security Upgrades Soon 
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies 
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
Trump Says Talks With UK PM Andy Burnham Went Well, Signals Meeting Soon 
South Korea’s Coupang Fine Sparks U.S. Criticism, Raising Concerns Over Bilateral Ties 
TrumpRx Expands Discount Drug Access With 600 Generic Medications 
Fed Chair Kevin Warsh Launches Task Forces to Overhaul U.S. Monetary Policy Framework 
NASA Resumes Cygnus XL Cargo Docking with Space Station After Software Fix 
xAI Sues Man for Allegedly Using Grok to Generate AI Child Abuse Deepfakes 
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak 
Ralph Norman Launches South Carolina Senate Bid After Lindsey Graham’s Death 
U.S. President Donald Trump has signed an executive order aimed at expanding the use of artificial intelligence (AI) in pediatric cancer research. The order provides an additional $50 million in research grants to accelerate progress in finding cures for childhood cancers, according to White House officials.
This move builds on the National Cancer Institute’s (NCI) Childhood Cancer Data Initiative, a decade-long, $500 million program launched in 2019 to collect and share vital data on pediatric cancers. Michael Kratsios, director of the White House Office of Science and Technology Policy, highlighted that childhood cancer remains the leading cause of disease-related deaths among children in the United States, with cases rising more than 40% since 1975.
Kratsios noted that advances in AI can now be harnessed to sharpen diagnoses, improve clinical trials, fine-tune treatment strategies, and enhance prevention methods. Data gathered through the NCI initiative is expected to empower researchers with new tools to tackle the complexity and diversity of pediatric cancers.
In addition to the $50 million in grants, the National Institutes of Health (NIH) will double its commitment by investing another $50 million. This funding aims to attract leading scientific teams through competitive research opportunities. Further investments are also anticipated to strengthen ongoing initiatives.
The announcement comes despite Trump’s 2026 budget proposal, which suggested a 37% cut to the NCI budget. Lawmakers in both the House and Senate, however, have pushed back against these cuts, and budget negotiations remain ongoing.
Globally, the World Health Organization reports that around 400,000 children and adolescents are diagnosed with cancer each year. While advances in adult cancer research have surged with AI, pediatric cancer research has lagged due to challenges like cancer rarity, diversity, and ethical concerns over patient data protection.
By reinforcing funding and leveraging AI, the administration aims to close this gap and accelerate life-saving innovations in childhood cancer treatment.
